Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures... see more

Recent & Breaking News (GREY:ISOLF)

Isodiol International Inc. Announces Licensing Agreement With Livecare Health Canada Inc. and Appoints Dr. Amit Mathur to Medical Advisory Board

GlobeNewswire January 26, 2018

Isodiol International Inc. Announces Extension of Licensing Agreement with Kathy Ireland and Level Brands

GlobeNewswire January 22, 2018

Isodiol International Inc. Signs Letter of Intent to Acquire 100% of Green Island Naturals

GlobeNewswire January 12, 2018

Isodiol International Inc. Signs Binding Supply Agreement with Namaste Technologies Inc.

GlobeNewswire January 12, 2018

Isodiol International Inc. Announces Letter of Intent to Import 99%+ Pure Pharma-Grade Cannabidiol to Canada From U.K. With Nuuvera

GlobeNewswire January 11, 2018

Isodiol signs agreement with organic products distributor

Stockhouse Editorial January 9, 2018

Isodiol International Inc. Provides Update on Be Tru Organics, Announces New Distribution Agreement

GlobeNewswire January 9, 2018

Isodiol signs licensing agreement with Level Brands

Stockhouse Editorial January 8, 2018

Isodiol International Inc. Signs Licensing Agreement with Level Brands Inc. and Its Chairman Emeritus And Chief Brand Strategist Kathy Ireland

GlobeNewswire January 8, 2018

kathy ireland Heath & Wellness, a Level Brands Business Unit, Enters into License with Isodiol Bringing the Parties Together in a Multimillion-Dollar Cannabidiol (CBD) Products Deal

Business Wire January 8, 2018

Isodiol International Inc. Announces Non-Binding Agreement With Licensed California Marijuana Manufacturer for Pot-O-Coffee

GlobeNewswire January 2, 2018

Isodiol International Announces $30 Million in Financing

Stockhouse Editorial December 21, 2017

Isodiol International Inc. Announces Strategic $30,000,000 CAD Financing

GlobeNewswire December 19, 2017

Isodiol International Inc. Announces Binding Agreement to Acquire Biosynthesis Pharma Group

GlobeNewswire December 17, 2017

Isodiol International Acquires Global Rights to produce products under an Innovative Delivery System Patent

GlobeNewswire December 15, 2017

Isodiol International Inc. Initiates Implementation of Blockchain Technology for Payment Processing

GlobeNewswire December 14, 2017

Isodiol International Inc. Provides Update on Be Trū Organics™, Announces New Distribution Channel

GlobeNewswire December 13, 2017

Isodiol enters Definitive Agreement to acquire 100% of C3 Global Sciences

Stockhouse Editorial December 8, 2017

Isodiol International Inc. Executes Definitive Agreement to Acquire 100% of C3 Global Biosciences™

GlobeNewswire December 8, 2017

Isodiol International Inc. Signs Definitive Agreement to Acquire 100% of Be Trū Organics™

GlobeNewswire December 8, 2017